PHC Holdings has resolved to transfer the Continuous Glucose Monitoring (CGM) system Eversense sales business of its consolidated subsidiary Ascensia Diabetes Care Holdings AG to Senseonics Holdings, Inc. for 1.1 million USD plus the net amount of transferred assets and liabilities, effective January 1, 2026.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"6523","jir_company_name":"PHC Holdings Corporation","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-01-05","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/01\/6523-20260105-01.pdf","jir_short_summary":"PHC Holdings has resolved to transfer the Continuous Glucose Monitoring (CGM) system Eversense sales business of its consolidated subsidiary Ascensia Diabetes Care Holdings AG to Senseonics Holdings, Inc. for 1.1 million USD plus the net amount of transferred assets and liabilities, effective January 1, 2026.","jir_summary":"### Overview of the Business Transfer\nPHC Holdings has resolved at its board meeting on January 1, 2026, to transfer the sales business of the Continuous Glucose Monitoring (CGM) system Eversense, developed by its consolidated subsidiary Ascensia Diabetes Care Holdings AG, to Senseonics Holdings, Inc. The transfer price is 1.1 million USD plus the net amount of the transferred assets and liabilities. The business transfer in the United States is scheduled for January 1, 2026, with completion outside the United States by June 30, 2026. Net sales for the fiscal year ending March 2025 were 3.06 billion yen, and operating income was \u25b39.0 billion yen. This transfer is part of portfolio management enhancement under the Medium-term Management Plan 2027, aiming to improve capital efficiency and reinforce the earnings base.\n\n### Transferee and Future Outlook\nThe transferee, Senseonics Holdings, Inc., headquartered in the United States, develops and manufactures proprietary long-term subcutaneously implantable Continuous Glucose Monitoring systems. PHC Holdings currently holds 9.56% of Senseonics Holdings' shares. The transfer was determined to be optimal as it allows an integrated system covering development, manufacturing, and sales. The impact on consolidated earnings has already been factored into the full-year earnings forecast revision announced on November 12, 2025, and there is currently no need for goodwill impairment. Any significant matters arising in the future will be promptly disclosed.","jir_financial_highlights":"Net Sales: 3.06 billion yen (Unknown)\nOperating Income: \u25b39.0 billion yen (Unknown)\nTransfer Price: 1.1 million USD and the net amount of transferred assets and liabilities (Unknown)","jir_category":"","jir_hashtags":"#PHCHoldingsCorporation, #m_and_a_alliance, #JapaneseStocks","jir_key_figures":"Net Sales: 3.06 billion yen (Fiscal Year Ending March 2025, Eversense Sales Business)\nOperating Income: \u25b39.0 billion yen (Fiscal Year Ending March 2025, Eversense Sales Business)\nTransfer Price: 1.1 million USD and the net amount of transferred assets and liabilities","jir_meta_title":"PHC Holdings Resolves to Transfer Ascensia's Eversense Sales Business for 1.1 Million USD (January 2026)","jir_meta_description":"PHC Holdings transfers the CGM system Eversense sales business of its consolidated subsidiary Ascensia to Senseonics Holdings. Fiscal year ending March 2025 net sales were 3.06 billion yen and operating income was \u25b39.0 billion yen. Transfer scheduled for January 1, 2026.","jir_og_title":"PHC Holdings Resolves Business Transfer of Eversense Sales to Senseonics","jir_og_description":"PHC Holdings has resolved to transfer the CGM system Eversense sales business of Ascensia to Senseonics for 1.1 million USD, effective January 1, 2026.","jir_og_image_url":"\/assets\/og\/company-m_and_a_alliance.jpg","jir_chart_data_collection":"[]","ir_related_company":9274,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"m_and_a_alliance","footnotes":""},"sector":[],"importance":[],"class_list":["post-10218","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n